Division of Human Genetics, Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland.
Clin Chem. 2010 Jul;56(7):1098-106. doi: 10.1373/clinchem.2009.142828. Epub 2010 May 14.
DNA methylation analysis currently requires complex multistep procedures based on bisulfite conversion of unmethylated cytosines or on methylation-sensitive endonucleases. To facilitate DNA methylation analysis, we have developed a quantitative 1-step assay for DNA methylation analysis.
The assay is based on combining methylation-sensitive FastDigest(R) endonuclease digestion and quantitative real-time PCR (qPCR) in a single reaction. The first step consists of DNA digestion, followed by endonuclease inactivation and qPCR. The degree of DNA methylation is evaluated by comparing the quantification cycles of a reaction containing a methylation-sensitive endonuclease with the reaction of a sham mixture containing no endonuclease. Control reactions interrogating an unmethylated locus allow the detection and correction of artifacts caused by endonuclease inhibitors, while simultaneously permitting copy number assessment of the locus of interest.
With our novel approach, we correctly diagnosed the imprinting disorders Prader-Willi syndrome and Angelman syndrome in 35 individuals by measuring methylation levels and copy numbers for the SNRPN (small nuclear ribonucleoprotein polypeptide N) promoter. We also demonstrated that the proposed correction model significantly (P < 0.05) increases the assay's accuracy with low-quality DNA, allowing analysis of DNA samples with decreased digestibility, as is often the case in retrospective studies.
Our novel DNA methylation assay reduces both the hands-on time and errors caused by handling and pipetting and allows methylation analyses to be completed within 90 min after DNA extraction. Combined with its precision and reliability, these features make the assay well suited for diagnostic procedures as well as high-throughput analyses.
DNA 甲基化分析目前需要基于亚硫酸氢盐将未甲基化的胞嘧啶或甲基化敏感内切酶进行复杂的多步处理。为了促进 DNA 甲基化分析,我们开发了一种用于 DNA 甲基化分析的定量一步法检测。
该检测基于将甲基化敏感的 FastDigest®内切酶消化和实时定量 PCR(qPCR)在单个反应中结合使用。第一步包括 DNA 消化,然后是内切酶失活和 qPCR。通过比较含有甲基化敏感内切酶的反应与不含内切酶的模拟混合物的反应的定量循环数,评估 DNA 甲基化程度。控制反应检测未甲基化基因座,可检测和纠正内切酶抑制剂引起的假象,同时允许对感兴趣基因座的拷贝数进行评估。
通过测量 SNRPN(小核核糖核蛋白多肽 N)启动子的甲基化水平和拷贝数,我们用我们的新方法正确诊断了 35 名个体的印迹障碍症 Prader-Willi 综合征和 Angelman 综合征。我们还表明,所提出的校正模型显著(P<0.05)提高了该检测在低质量 DNA 中的准确性,允许分析消化能力降低的 DNA 样本,这在回顾性研究中经常发生。
我们的新型 DNA 甲基化检测减少了操作时间和手动处理及移液引起的错误,并允许在 DNA 提取后 90 分钟内完成甲基化分析。结合其精确性和可靠性,这些特性使该检测非常适合诊断程序以及高通量分析。